Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
3
×
drug pricing
3
×
life sciences
biotech
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
eli lilly
fda
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
advaxis
aimmune therapeutics
alder biopharmaceuticals
alex azar
alexander hardy
alliance for aging research
amgen
andrew oxtoby
babies
biogen
bioinnovation capital
biolabs
What
drug
industry
administration
angry
anti
benefited
big
bio
biotech
bosley's
bosley’s
bridge
bucks
cas
ceo
crime
crispr
departure
despite
driving
editas
exit
fear
good
guiding
healthcare
history
improved
innovation
innovations
investment
katrine
life
long
losing
medical
medicine
moves
outcomes
personnel
Language
unset
Current search:
" drug pricing "
×
" boston blog main "
×
@xconomy.com
4 years ago
Drug Pricing: Innovation, Investment, and the Public Good
@xconomy.com
5 years ago
Losing “Scalps”? Despite Pharma Fear, A Split on Trump Rx-Price Plans
@xconomy.com
5 years ago
Bio Roundup: Bosley’s Editas Exit, Bridge Bucks, CRISPR Crime & More
